Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Avidity Biosciences Inc shares valued at $297,491 were sold by Hughes Steven George on Mar 20 ’25. At $31.06 per share, Hughes Steven George sold 9,578 shares. The insider’s holdings dropped to 72,850 shares worth approximately $2.37 million following the completion of this transaction.
Also, Boyce Sarah sold 31,540 shares, netting a total of over 979,563 in proceeds. Following the sale of shares at $31.06 each, the insider now holds 305,871 shares.
Before that, Flanagan W. Michael had sold 11,780 shares from its account. In a trade valued at $365,868, the Chief Scientific Officer traded Avidity Biosciences Inc shares for $31.06 each. Upon closing the transaction, the insider’s holdings decreased to 11,780 shares, worth approximately $2.61 million.
As published in their initiating research note from Citigroup on March 13, 2025, Avidity Biosciences Inc [RNA] has been a Buy and the price target has been revised to $70. Analysts at BMO Capital Markets started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid March. As of March 07, 2025, Scotiabank has initiated its “Sector outperform” rating for RNA. Earlier on December 20, 2024, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for RNA stock.
Analyzing RNA Stock Performance
During the last five days, there has been a surge of approximately 5.61%. Over the course of the year, Avidity Biosciences Inc shares have jumped approximately 11.97%. Shares of the company reached a 52-week high of $36.38 on 03/13/25 and a 52-week low of $26.74 on 01/14/25. A 50-day SMA is recorded $31.38, while a 200-day SMA reached $38.94.
Support And Resistance Levels for Avidity Biosciences Inc (RNA)
According to the 24-hour chart, there is a support level at 32.01, which, if violated, would cause prices to drop to 31.47. In the upper region, resistance lies at 33.12. The next price resistance is at 33.68. RSI (Relative Strength Index) is 53.80 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.58, which suggests the price will decrease in the coming days. Percent R is at 51.21%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
